Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Use of Postpartum uterine curettage in reducing hospitalization time or in improving the clinical evolution of the patient with preeclampsia/eclampsia.
To evaluate if postpartum uterine curettage improved the clinical and laboratory parameters in patients with preeclampsia or eclampsia.
A total of 442 patients with preeclampsia/eclampsia were randomized to postpartum curettage (223) or no procedure (219). Systolic and diastolic blood pressure were recorded and analyzed at hours 6, 12, 24 and 48. Also, several laboratory values and diuresis were evaluated.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Curettage | Experimental | Postpartum uterine curettage performed immediately after delivery of the placenta. |
|
| Placebo | Placebo Comparator | No procedure performed after delivery of the placenta. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Curettage | Procedure | Postpartum uterine curettage with a sharp curette # 14 or #16, immediately after delivery of the placenta. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Systolic and diastolic blood pressure | Arterial blood pressure | 6 hours |
| Systolic and diastolic blood pressure | Arterial blood pressure | 12 hours |
| Systolic and diastolic blood pressure | Arterial blood pressure | 24 hours |
| Systolic and diastolic blood pressure | Arterial Blood pressure | 48 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests). | Number of patients with an abnormal laboratory value | 6 hours |
| Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Osvaldo Reyes, MD | Saint Thomas Hospital, Panama | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saint Thomas H | Panama City | Provincia de Panamá | Panama | |||
| Saint Thomas Maternity Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011225 | Pre-Eclampsia |
| D004461 | Eclampsia |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D003475 | Curettage |
| ID | Term |
|---|---|
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Procedure | No procedure after delivery of the placenta |
|
Number of patients with an abnormal laboratory value |
| 12 hours |
| Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests). | Number of patients with an abnormal laboratory value | 24 hours |
| Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests). | Number of patients with an abnormal laboratory value | 48 hours |
| Seizures | Number of participants with the development of seizures after birth. | 48 hours |
| Panama City |
| Provincia de Panamá |
| Panama |